Predictors of death in infants hospitalized with pertussis: A case-control study of 16 pertussis deaths in Canada

Journal of Pediatrics

Volumn 143, Issue 5, 2003, Pages 576-581

  Mikelova, Lynda K ^b   Halperin, Scott A ^a   Scheifele, David ^b   Smith, Bruce ^b   Ford Jones, Elizabeth ^b   Vaudry, Wendy ^b   Jadavji, Taj ^b   Law, Barbara ^b   Moore, Dorothy ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEPHALOSPORIN; ERYTHROMYCIN; MACROLIDE; VANCOMYCIN;

AGE; ARTICLE; CANADA; CASE CONTROL STUDY; CHILD DEATH; CHILD HOSPITALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE COURSE; FATALITY; FEMALE; FISHER EXACT TEST; GEOGRAPHY; HEALTH PROGRAM; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; INFANT; LEUKOCYTE COUNT; LEUKOCYTOSIS; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL CARE; MULTIVARIATE ANALYSIS; NEWBORN; PERTUSSIS; PNEUMONIA; PREDICTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; TIME;

EID: 0344708483     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00365-2     Document Type: Article

References (30)

1. Varughese P. Incidence of pertussis in Canada. CMAJ 1985;132:1041-2.
2. Centers for Disease Control and Prevention. Pertussis - United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002;51:73-6.
3. Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 1994;13:343-5.
4. Farizo KM, Cochi SL, Zell ER, Brink E, Wassilak SCF, Patriarca PA. Epidemiologic features of pertussis in the United States, 1980B1989. Clin Infect Dis 1992;14:708B19.
5. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-7.
6. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002;185:1448-53.
7. Sutter RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA 1992;267:386-91.
8. Crowcroft NS, Andrews N, Rooney C, Brisson M, Miller E. Deaths from pertussis are underestimated in England. Arch Dis Child 2002;86:336-8.
9. Gilberg S, Njamkepo E, Du Chatelet IP, Partouche H, Gueirard P, Ghasarossian C, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002;186:415-8.
10. Floret D, Group de pathologie infectieuse pediatrique, Groupe francophone de reanimation et d'urgence pediatrique. Pediatric deaths due to community-acquired bacterial infection. Survey of French pediatric intensive care units. Arch Pediatr 2001;(8 Suppl):705s-11s.
11. Halperin SA, Wang EE, Law B, Mills E, Morris R, Dery P, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999;28:1238-43.
12. Morris R, Halperin S, Déry P, Mills E, Lebel M, MacDonald N, et al. IMPACT monitoring network: a better mousetrap. Can J Infect Dis 1993;4:194-5.
13. Scheifele DW, Halperin SA, Gold R, Samson H, King A, and members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program, ACTive (IMPACT). Assuring vaccine safety: a celebration of 10 years of progress with the IMPACT project. Paediatr Child Health 2002;7:645-8.
14. Wortis N, Strebel PM, Wharton M, Bardenheier B, Hardy IR. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics 1996;97:607-12.
15. Miller E, Vurdien JE, White JM. The epidemiology of pertussis in England and Wales. Commun Dis Rep CDR Rev 1992;2:R152-4.
16. Pierce C, Klein N, Peters M. Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med 2000;26:1512-4.
17. Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal. Eur J Pediatr 2000;159:898-900.
18. Sreeman CD, Osiovich H. Neonatal pertussis requiring extracorporeal membrane oxygenation. Pediatr Surg Int 2001;17:201-3.
19. Williams GD, Matthews NT, Choong RKC, Ferson M. Infant pertussis deaths in New South Wales 1996-1997. Med J Aust 1998;168: 281-3.
20. di Sant'Agnese PA. Combined immunization against diphtheria, tetanus and pertussis in newborn infants. III. Relationship of age to antibody protection. Pediatrics 1949;3:333-44.
21. Halsey N, Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ 1985;63:1151-69.
22. Lieberman JM, Greenberg DP, Wong VK, Partridge S, Chang SJ, Chiu CY, et al. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J Pediatr 1995;126:198-205.
23. Campins-Martí M, Cheng H, Forsyth K, Guiso N, Halperin S, Huang L, et al. International Consensus Group on Pertussis Immunisation. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001; 20:641-6.
24. Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, Drucker J, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998; 17:412-8.
25. Wirsing von König CH, Postels-Multani S, Bogaerts H, Bock HL, Laukamp S, Kiederle S, et al. Factors influencing the spread of pertussis in households. Eur J Pediatr 1998;157:391-4.
26. Grimprel E, Baron S, Lévy-Bruhl D, Garnier JM, N'jamkepo E, Guiso N. Influence of vaccination coverage on pertussis transmission in France. Lancet 1999;354:1699-700.
27. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults. J Infect Dis 2000;182:1409-16.
28. Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000;18:1312-9.
29. Van der Wielen M, Van Damme P, Joossens E, François G, Meurice F, Ramalho A. A randomized controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults. Vaccine 2000;18:2075-82.
30. Ward J, Partridge S, Chang S, Lee H, Cherry J, Greenberg D, et al. Acellular pertussis vaccine efficacy and epidemiology of pertussis in adolescents and adults: NIH multicenter adult pertussis trial (APERT). Presented at the Acellular Pertussis Vaccine Conference (NIAID, FDA, CDC, AAP, NVP), November 12-14, 2000, Bethesda, Maryland.